Cite
HARVARD Citation
Wuerstlein, R. et al. (n.d.). The West German Study Group Breast Cancer Intrinsic Subtype study: a prospective multicenter decision impact study utilizing the Prosigna assay for adjuvant treatment decision-making in estrogen-receptor-positive, HER2-negative early-stage breast cancer. Current medical research and opinion. pp. 1217-1224. [Online].